NuvoMed, Inc. — Form D
NuvoMed, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-18. The offering totals $535K, of which $485K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-04-18
- Form: D
- Accession: 0001574541-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $535K
- Amount sold: $485K
- Remaining: $50K
- Minimum investment: $13K
- Investors: 12
- Date of first sale: 2013-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-195192
Issuer
- Name: NuvoMed, Inc.
- CIK: 0001574541
- Entity type: Corporation
- Jurisdiction: ARIZONA
- Incorporated: 2012
- Address: 2300 E. ROY STREET, SEATTLE, WA, 98112
- Phone: 206-999-9387
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kent T Smith | Director | Coralville, IA |
| Rick T Gibson | Director | Tucson, AZ |
| Ashley S Williams | Director | Seattle, WA |
| Ashley S Williams | Executive Officer | Seattle, WA |
| Shelly T Lanning | Director | New York, NY |
| Burton S Bentley, II | Director | Tucson, AZ |
Other filings by this issuer (2)
More